Amid a groundswell of questions…
Amid a groundswell of questions and pushback over the FDA’s [...]
Amid a groundswell of questions and pushback over the FDA’s [...]
Novo Nordisk is hitting the gas on amycretin development. After [...]
A drug safety group has delivered a positive analysis for [...]
Swedish biotech Sprint Bioscience is selling off an early-stage TREX1 [...]
A few months after SK Life Science began rolling out [...]
Novo Nordisk has come up short in two phase 3 [...]
VC Versant Ventures is unveiling Dayra Therapeutics, a new biotech [...]
A combination of Merck-partnered sac-TMT and Keytruda led to a [...]
Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk [...]
Los estudios sobre adultos que toman ISRS muestran que estos [...]